PPARG and metabolic dysfunction-associated steatotic liver disease: Thus, expanding our knowledge of the ncRNAs/PPARγ regulatory axis may help us better understand how epigenetic mechanisms contribute to the physiopathology of NAFLD and advance the process of developing potential ncRNAs/PPARγ-based therapeutics for this condition.